Keyphrases
Age of Onset
7%
Alpha-synuclein (α-syn)
17%
Alzheimer's Disease
9%
Baboon
5%
Basal Ganglia
6%
Botulinum Neurotoxin (BoNT)
5%
Cervical Dystonia
10%
Confidence Interval
9%
D2 Receptor
7%
Deep Brain Stimulation
12%
Dementia
5%
Dopamine
9%
Dopamine D2 Receptor (DRD2)
5%
Dystonia
18%
Gait
5%
Huntington's Disease
21%
Idiopathic Parkinson's Disease
10%
Leucine-rich Repeat Kinase 2 (LRRK2)
5%
Levodopa
12%
Macaque
6%
Manganese
10%
Manganese Exposure
7%
Medicare Beneficiaries
5%
Monkey
6%
Movement Disorders
6%
Neurodegenerative Diseases
8%
Nonhuman Primate
13%
Odds Ratio
5%
Parkinson Patients
7%
Parkinson's Disease
100%
Parkinsonism
16%
Pathophysiology
6%
Patients with Parkinson's Disease
7%
Positron Emission Tomography
22%
Premanifest Huntington's Disease
5%
Radioligand
10%
Radiosynthesis
5%
Radiotracer
7%
Receptor Binding
8%
Regional Cerebral Blood Flow (rCBF)
6%
Sphingosine-1-phosphate Receptor (S1PR)
5%
Striatal
10%
Striatum
7%
Subthalamic nucleus
5%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
8%
Tremor
5%
Unified Parkinson's Disease Rating Scale (UPDRS)
10%
Vesicular Acetylcholine Transporter (VAChT)
7%
Welders
5%
Neuroscience
Alzheimer's Disease
10%
Amyloid
7%
Basal Ganglia
8%
Behavior (Neuroscience)
9%
Cerebellum
6%
Dopaminergic
11%
Dystonia
19%
Eicosanoid Receptor
6%
Electrical Brain Stimulation
14%
Fluorine-18
18%
Functional Magnetic Resonance Imaging
5%
Huntington's Disease
14%
In Vitro
8%
In Vivo
15%
L-DOPA
11%
Magnetic Resonance Imaging
5%
Neurodegenerative Disorder
7%
Parkinson's Disease
91%
Parkinsonism
15%
Positron Emission Tomography
25%
Positron Emission Tomography
12%
Putamen
7%
Radioligand
10%
Receptor Binding
7%
Spasmodic torticollis
7%
Stereotypic Movement Disorder
8%
Striatum
7%
Subthalamic Nucleus
10%
Synuclein
9%
Tremor
10%
Vesicular Acetylcholine Transporter
5%